Wuhan Keqian Biology Co Ltd (688526) — Cash Flow Reinvestment Rate
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥11.35 Million (capex CN¥11.35 Million ) from operating cash flow of CN¥174.36 Million. Check 688526 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Keqian Biology Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Wuhan Keqian Biology Co Ltd across 9 annual periods. Explore Wuhan Keqian Biology Co Ltd (688526) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Wuhan Keqian Biology Co Ltd. For live market cap and broader valuation context, see 688526 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.78x | CN¥307.88 Million | CN¥392.68 Million | CN¥106.94 Million | ▼ -2.7% |
| 2023 | 0.81x | CN¥433.50 Million | CN¥538.03 Million | CN¥104.50 Million | ▼ -53.9% |
| 2022 | 1.75x | CN¥739.98 Million | CN¥423.71 Million | CN¥102.85 Million | ▲ +31.5% |
| 2021 | 1.33x | CN¥705.55 Million | CN¥531.27 Million | CN¥374.45 Million | ▼ -59.2% |
| 2020 | 3.25x | CN¥1.30 Billion | CN¥400.14 Million | CN¥111.60 Million | ▼ -33.8% |
| 2019 | 4.92x | CN¥761.46 Million | CN¥154.89 Million | CN¥137.74 Million | ▲ +5404.8% |
| 2018 | 0.09x | CN¥31.42 Million | CN¥351.83 Million | CN¥31.42 Million | ▼ -76.6% |
| 2017 | 0.38x | CN¥129.11 Million | CN¥337.61 Million | CN¥129.11 Million | ▲ +189.7% |
| 2016 | 0.13x | CN¥29.13 Million | CN¥220.69 Million | CN¥29.13 Million | — |